New Zealand markets closed

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
92.25-0.72 (-0.77%)
At close: 04:00PM EDT
92.30 +0.05 (+0.05%)
After hours: 07:35PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 21.94B
Enterprise value 4.26B
Trailing P/E 22.25
Forward P/E 7.04
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.42
Price/book (mrq)1.00
Enterprise value/revenue 1.11
Enterprise value/EBITDA 3.91

Trading information

Stock price history

Beta (5Y monthly) 0.23
52-week change 3-25.95%
S&P500 52-week change 327.86%
52-week high 3131.52
52-week low 385.21
50-day moving average 393.53
200-day moving average 3102.92

Share statistics

Avg vol (3-month) 3692.25k
Avg vol (10-day) 3821.22k
Shares outstanding 5237.73M
Implied shares outstanding 6237.73M
Float 886.72M
% held by insiders 163.98%
% held by institutions 118.40%
Shares short (15 Mar 2024) 43.08M
Short ratio (15 Mar 2024) 45.56
Short % of float (15 Mar 2024) 46.43%
Short % of shares outstanding (15 Mar 2024) 41.30%
Shares short (prior month 15 Feb 2024) 43.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 317 Jun 2022
Ex-dividend date 402 Jun 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 24.36%
Operating margin (ttm)40.00%

Management effectiveness

Return on assets (ttm)2.62%
Return on equity (ttm)4.62%

Income statement

Revenue (ttm)3.82B
Revenue per share (ttm)15.87
Quarterly revenue growth (yoy)-65.40%
Gross profit (ttm)N/A
EBITDA 1.11B
Net income avi to common (ttm)930.3M
Diluted EPS (ttm)4.15
Quarterly earnings growth (yoy)-79.90%

Balance sheet

Total cash (mrq)16.55B
Total cash per share (mrq)69.61
Total debt (mrq)219.1M
Total debt/equity (mrq)1.08%
Current ratio (mrq)9.43
Book value per share (mrq)85.17

Cash flow statement

Operating cash flow (ttm)5.37B
Levered free cash flow (ttm)4.14B